docetaxel,rucaparib,abiraterone,enzalutamide
pfizer,astellas,clovis oncology
['rucaparib', 'prostate', 'crpc', 'docetaxel', 'triton3']
#ascogu23. today at 16:20 gmt/ 10:20 cst, oral abstract session a: prostate cancer.
alan haruo bryce presents 'rucaparib for mcrpc: triton3 interim overall survival &amp; efficacy of rucaparib vs docetaxel or second-generation androgen pathway inhibitor therapy.'
abstract: 18
#meded
COR2ED bringing you Independent Medical Education developed 
by GU CONNECT, international experts in GenitoUrinary (GU) oncology